Phase 3 Trial of <sup>177</sup> Lu-Dotatate for Midgut Neuroendocrine TumorsJonathan Strosberg, Eric P. Krenning, James C. Yao et al.|New England Journal of Medicine|2017Cited by 3.2k
High tumor incidence and activation of the PI3K/AKT pathway in transgenic mice define AIB1 as an oncogeneMaria I. Torres‐Arzayus, Myles Brown, Jaime Font de Mora et al.|Cancer Cell|2004Cited by 379